JY
TERN

Jeff Yass’s Terns Pharmaceuticals TERN Stock Holding History

Jeff Yass’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-597,300
Closed -$31.5M – 14516
2026
Q1 		$31.5M Buy
597,300
+531,100
+802% +$21.8M ﹤0.01% 1686
2025
Q4 		$2.67M Buy
66,200
+53,100
+405% +$1.23M ﹤0.01% 5087
2025
Q3 		$98.4K Buy
+13,100
New +$83.6K ﹤0.01% 11575
2025
Q1 		– Sell
-43,400
Closed -$240K – 13449
2024
Q4 		$240K Sell
43,400
-126,700
-74% -$858K ﹤0.01% 10299
2024
Q3 		$1.42M Buy
170,100
+89,400
+111% +$736K ﹤0.01% 6031
2024
Q2 		$550K Buy
80,700
+51,600
+177% +$313K ﹤0.01% 8044
2024
Q1 		$191K Buy
29,100
+6,400
+28% +$41.8K ﹤0.01% 10640
2023
Q4 		$147K Buy
+22,700
New +$120K ﹤0.01% 10993
2023
Q3 		– Sell
-92,000
Closed -$805K – 12967
2023
Q2 		$805K Buy
+92,000
New +$1.07M ﹤0.01% 7185

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jeff Yass's TERN Position: Q2 2026 in Review

Jeff Yass sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 521,571 shares — an estimated $27.5M sold.

Jeff Yass first reported a position in TERN in Q4 2022 and held it in 13 quarters. The position peaked at $27.5M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Jeff Yass reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 521,571 Terns Pharmaceuticals shares in Q2 2026, an estimated $27.5M.
  • Jeff Yass first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 13 quarters.
  • Jeff Yass's Terns Pharmaceuticals position peaked at $27.5M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.